Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Guess not. This thing has crashed with not very much volume.
8 days in a row, red...gotta bounce at some point...no?
Nice buy, looks like it's finally bottoming out.
CLDN
SS
Added $1.25 this morning.
CLDN
SS
http://www.wallstreetscope.com/investigation-for-investors-in-shares-of-celladon-corp-nasdaqcldn-over-acquisition-announced/25531436/
Investigation for Investors in shares of Celladon Corp (NASDAQ:CLDN) over Acquisition announced
The takeover of Celladon is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NASDAQ:CLDN shares concerning whether the takeover of Celladon Corp. is unfair to NASDAQ:CLDN stockholders.
Investors who purchased shares of Celladon Corp (NASDAQ:CLDN) and currently hold any of those NASDAQ:CLDN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain officers and directors of Celladon Corp breached their fiduciary duties owed to NASDAQ:CLDN investors in connection with the proposed acquisition.
On November 18, 2015 Celladon Corp (NASDAQ:CLDN) and Eiger BioPharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced that they have entered into a merger agreement under which the stockholders of Eiger would become the majority owners of Celladon, and the operations of Celladon and Eiger would be combined.
That's good. Yours are still green but we always hate see our profits vanish. That's why I decided to go ahead and take mine but hope I can get in again.
We were in at 1.31
If it does, maybe you can average down. How low do you think it'll get?
Yes, I am a shareholder. I got mine at $1.74 and I'm a bit concerned that it will go even lower.
I didn't know you sold and took your profits already. Good for you!!!
Sorry, I have no idea. What do you think it'll be? I'm curious; are you a shareholder? You seem to be concerned that I might lose money after I've already taken my profits.
I just now came home and see that the sp hit 1.48. I sold my shs yesterday but might buy them back if it goes low enough. I don't remember what you paid for yours but some of mine were 1.295.
What do you think is the SP for CLDN by the time of the merger?
Taking a beating here too, everything I'm in is getting beat up
Marilynt,
Based on information we have at present, on a pro forma basis for the combined company, current Celladon shareholders are expected to own approximately 22%, current Eiger shareholders approximately 45% and the new Eiger investor syndicate approximately 33%, each on a fully-diluted basis.
An investor syndicate has committed to invest $39.5 million in the combined company --- Six million dollars of the financing has already been funded, and the remaining $33.5 million is expected to close contemporaneously with the completion of the proposed merger.
Therefore, $39.5MM / 33% = $119MM is the valuation for the new company. Based on the 22% share, the investors valued the current CLDN at $26MM which is quite low vs. its current market cap of $37MM.
Your thoughts?
Celladon Corp (NASDAQ:CLDN) And Eiger BioPharmaceuticals Sign Merger Agreement
http://www.financialstrend.com/celladon-corp-nasdaqcldn-and-eiger-biopharmaceuticals-sign-merger-agreement-23892.html
Celladon Corp (NASDAQ:CLDN) reported that it has finalized a definitive merger deal with a privately held biopharmaceutical firm known as Eiger BioPharmaceuticals, Inc. Under the finalized agreement the stockholders of Eiger BioPharmaceuticals would become the majority stake owners of Celladon, and the businesses of Eiger and Celladon would be combined. The announced merger deal remains subject to certain conditions, such as the approval of Celladon shareholders. If the deal gets approved, after closing of the deal, Celladon will be renamed as “Eiger BioPharmaceuticals, Inc.”
The details
An investor organization has committed to invest nearly $40 million in the new combined entity including new investors RA Capital Management, HBM Healthcare Investments, Sphera Global Healthcare,Sabby Management, Monashee Capital Partners and Perceptive Advisors together with existing Eiger stockholders, InterWest Partners and ViVo Capital. Six million dollars financing has been funded, and the remaining funds of $33.5 million is projected to complete contemporaneously with the close of the proposed deal.
The cash balance of the combined entity upon the closing of the deal and the financing is estimated to surpass $60 million. This merger deal will create a clinical-stage firm with a diversified development portfolio of candidates addressing unique targets for four different orphan diseases: bariatric surgery-resulted hyperinsulinemic hypoglycemia, Hepatitis Delta Virus, lymphedema and pulmonary arterial hypertension.
The expert speaks
David Cory, the CEO of Eiger, said that the concurrent financing and the proposed merger deal are expected to be sufficient to enable the combined entity to receive Phase II clinical study data from at least two of the total four designed development plans by late 2016. The company has an experienced and dedicated management team in place and implementing on these four novel plans, all of which target potentially large markets with significant unmet medical needs. Celladon Corp (NASDAQ:CLDN)’s CEO Paul Cleveland said that after an extensive assessment of strategic alternatives, they have finalized for the merger deal with Eiger.
Is this cause for concern?
Celladon is expected to issue approximately 85.0 million new shares of its common stock to Eiger stockholders and participants in the financing. On a pro forma basis for the combined company, current Celladon shareholders are expected to own approximately 22%, current Eiger shareholders approximately 45% and the new Eiger investor syndicate approximately 33%, each on a fully-diluted basis.
Yes CLDN trades strange for sure.
SS
Incredible. Yesterday AH 2.2 now again to test the support 1.60.
Nice 45k bid @ 1.69
CLDN
SS
Hi mantisforce. When the merger goes through the shs at this level will look like a real bargain.
There's a 130K block on the ask @1.82 and it's probably keeping buyers away. It was probably placed by a short.
Howdy Marilynt, I got a cldn position last week. I found this company while I was searching penny bio-stocks.
I'm here, low volume day but CLDN is holding above 2nd support so far.
SS
That sounds good.
GLTY
CLDN / Eiger - after merger, should be worth 2.50 just in cash on hand. With the pipeline added I can see this getting to $5 soon after the merger, maybe a lot higher. all imo, glta longs
Thanks, I think so. Chart looks good and volume strong. Little risk IMO.
It's nice to see your shs turn green so soon. You made a good decision.
Thanks Marilynt. Just bought looking at the chart and seeing the volume.
Welcome to the CLDN board and congrats on your buy.
Grabbed 3,000 shares today. Avg $1.70ish. GLTA.
shocked it fell back a/h whats in that 8-k/
CLDN
Could gap up tommarow gl all ..
Alll imo !
That's great! And your shs already green! Congrats.
I have bought today !
Thank you Marilyn :)
I gave this one out to some family members and they jumped in, so I'm gonna win on this anyway because now my family will think I'm great. The last stock tip I gave them the company filed bankruptcy, so it took them a couple years before they would trust me again. lol
Thanks. I wish you had shs.
Never did get any as all my stuff is tied up,but I'm happy for you.
From 8k
Reorganization ("Merger Agreement"), pursuant to which, among other things, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Eiger, with Eiger becoming a wholly-owned subsidiary of Celladon and the surviving corporation of the merger.
Thanks, homeboy4u. Do you have shs?
Thanks Marilyn, and congratulations you really deserve a winner like this!
Yes, it is great news!
CLDN
1
Ok ,so it's a definite merger..great news !
Wow 8k out Boom time folks enjoy the ride up
From $2.30 back to $1.84..crazy .46 cent difference in a minute.
Hopefully tomorrow it continues up over 2 buckaroos !
Now back to 1.93
Followers
|
32
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1047
|
Created
|
12/03/14
|
Type
|
Free
|
Moderators |
About the Proposed Merger
Existing Eiger stockholders as well as investors in the contemporaneous financing will receive newly issued shares of Celladon common stock in connection with the proposed merger. Celladon is expected to issue approximately 85.0 million new shares of its common stock to Eiger stockholders and participants in the financing. On a pro forma basis for the combined company, current Celladon shareholders are expected to own approximately 22%, current Eiger shareholders approximately 45% and the new Eiger investor syndicate approximately 33%, each on a fully-diluted basis.
The transaction has been unanimously approved by the boards of directors of both companies, and a majority of Eiger stockholders have agreed to vote in favor of the transaction. The proposed merger is expected to close in the first half of 2016, subject to the approval of the stockholders of each company as well as regulatory approval and other customary conditions. The merger agreement contains further details with respect to the proposed merger.
Celladon’s exclusive financial advisor in the transaction is Wedbush PacGrow Healthcare. Jefferies LLC is acting as lead financial advisor to Eiger and Piper Jaffray is acting as financial advisor. Pillsbury Winthrop Shaw Pittman LLP served as legal counsel to Celladon and Cooley LLP served as legal counsel to Eiger.
Chart
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |